Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda

Overview of attention for article published in BMC Infectious Diseases, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 88 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 114 followers.

RT @jigw050681: Es conocida la no inferioridad y la disminución de efectos adversos de switch de esquemas con efavirenz a esquemas con D…

09 Dec 2022

Reply Repost Favourite

Es conocida la no inferioridad y la disminución de efectos adversos de switch de esquemas con efavirenz a esquemas con Dolutegravir , es muy importante acompañar durante el proceso de switch , y responder ante las dudas que puedan tener los pacientes. h

09 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.